New Risk • Jul 08
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: €87.2m (US$99.6m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 3.9% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.8% average weekly change). Market cap is less than US$100m (€87.2m market cap, or US$99.6m). Aankondiging • Jun 29
Ultralife Corporation(NasdaqGM:ULBI) dropped from Russell Microcap Growth Benchmark Index Ultralife Corporation(NasdaqGM:ULBI) dropped from Russell Microcap Growth Benchmark Index Board Change • Jun 17
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. Independent Director Janie Goddard was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Aankondiging • Jun 03
Ultralife Corporation, Annual General Meeting, Jul 22, 2026 Ultralife Corporation, Annual General Meeting, Jul 22, 2026. Location: 2020 convention center concourse, atlanta, ga, 30337, United States Aankondiging • May 02
Ultralife Corporation to Report Q1, 2026 Results on May 08, 2026 Ultralife Corporation announced that they will report Q1, 2026 results at 9:30 AM, US Eastern Standard Time on May 08, 2026 Aankondiging • Mar 18
Ultralife Corporation announced delayed annual 10-K filing On 03/17/2026, Ultralife Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC. Aankondiging • Mar 10
Ultralife Corporation Reports Unaudited Impairment Results for the Fourth Quarter Ended December 31, 2025 Ultralife Corporation reported unaudited impairment results for the fourth quarter ended December 31, 2025. For the period, the company reported intangible asset impairment of $12,181,000. In the quarter of 2025, the company decided to undergo a comprehensive rebranding initiative that consolidated all sub-brands under a singular, unified master brand – Ultralife. To this end, the Accutronics, Southwest Electronic Energy, Excell Battery, McDowell Research and AMTI brands will no longer be used. The Electrochem brand will remain in use, but as a product brand on select primary cells. As a result of the rebranding initiative, the company recorded a $12.2 million non-cash charge to reduce the value of the company’s tradename and trademark intangible assets. Aankondiging • Mar 06
Ultralife Corporation to Report Q4, 2025 Results on Mar 10, 2026 Ultralife Corporation announced that they will report Q4, 2025 results Pre-Market on Mar 10, 2026 Aankondiging • Nov 14
Ultralife Corporation to Report Q3, 2025 Results on Nov 18, 2025 Ultralife Corporation announced that they will report Q3, 2025 results at 9:30 AM, US Eastern Standard Time on Nov 18, 2025 Aankondiging • Nov 08
Ultralife Corporation announced delayed 10-Q filing On 11/07/2025, Ultralife Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Aankondiging • Jul 29
Ultralife Corporation to Report Q2, 2025 Results on Aug 07, 2025 Ultralife Corporation announced that they will report Q2, 2025 results Pre-Market on Aug 07, 2025 Aankondiging • May 29
Ultralife Corporation, Annual General Meeting, Jul 16, 2025 Ultralife Corporation, Annual General Meeting, Jul 16, 2025. Location: atlanta airport marriott gateway, 2020 convention center concourse, ga 30337, atlanta United States Aankondiging • Apr 29
Ultralife Corporation to Report Q1, 2025 Results on May 09, 2025 Ultralife Corporation announced that they will report Q1, 2025 results Pre-Market on May 09, 2025 Aankondiging • Mar 09
Ultralife Corporation announced delayed annual 10-K filing On 03/07/2025, Ultralife Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC. Aankondiging • Feb 26
Ultralife Corporation to Report Q4, 2024 Results on Mar 11, 2025 Ultralife Corporation announced that they will report Q4, 2024 results Pre-Market on Mar 11, 2025 Aankondiging • Jan 06
Ultralife Corporation Announces the Appointment of Jeffrey Luke as Chief Marketing Officer and James Pope as Senior Vice President - Sales & Business Development, Battery & Energy Products, Effective January 6, 2025 Ultralife Corporation announced the appointment of Jeffrey Luke as Chief Marketing Officer and James Pope as Senior Vice President - Sales & Business Development, Battery & Energy Products, effective January 6, 2025. As Chief Marketing Officer, Jeff will be responsible for reframing corporate and brand strategies, providing alignment and accountability throughout the global organization. He will collaborate closely with sales and engineering teams to develop and execute effective go-to-market strategies, ensuring that Ultralife’s products and solutions meet the evolving needs of customers. Jeff brings over two decades of experience in B2B marketing, including genomics, agriculture, heavy equipment, energy and industrial computing. In his new role, James will focus on expanding reach into both existing and new markets and applications, and on aligning the efforts of global sales and business development teams in pursuing opportunities that maximize revenue, build strategic partnerships, and strengthen presence in competitive markets. He brings over thirty-seven years of experience in the battery and power industry, with a career that spans all major segments of the industry, including cell manufacturing, pack manufacturing, charger development, and work with representative organizations supporting battery and power solutions. New Risk • Nov 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Reported Earnings • Nov 10
Third quarter 2024 earnings released: EPS: US$0.016 (vs US$0.082 in 3Q 2023) Third quarter 2024 results: EPS: US$0.016 (down from US$0.082 in 3Q 2023). Revenue: US$35.7m (down 9.6% from 3Q 2023). Net income: US$258.0k (down 81% from 3Q 2023). Profit margin: 0.7% (down from 3.4% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 9.4% p.a. on average during the next 2 years, compared to a 7.2% growth forecast for the Electrical industry in Germany. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Aankondiging • Oct 24
Ultralife Corporation to Report Q3, 2024 Results on Nov 08, 2024 Ultralife Corporation announced that they will report Q3, 2024 results Pre-Market on Nov 08, 2024 Aankondiging • Oct 01
Ultralife Corporation (NasdaqGM:ULBI) signed a stock purchase agreement to acquire Electrochem Solutions, Inc. from Integer Holdings Corporation (NYSE:ITGR) for $50 million. Ultralife Corporation (NasdaqGM:ULBI) signed a stock purchase agreement to acquire Electrochem Solutions, Inc. from Integer Holdings Corporation (NYSE:ITGR) for $50 million on September 30, 2024. A cash consideration of $50 million will be paid by Ultralife Corporation. As part of consideration, $50 million is paid towards common equity of Electrochem Solutions, Inc. Ultralife expects to finance the transaction through its primary lender.
The expected completion of the transaction is by the end of October 2024. Reported Earnings • Jul 26
Second quarter 2024 earnings released: EPS: US$0.18 (vs US$0.21 in 2Q 2023) Second quarter 2024 results: EPS: US$0.18 (down from US$0.21 in 2Q 2023). Revenue: US$43.0m (flat on 2Q 2023). Net income: US$2.97m (down 11% from 2Q 2023). Profit margin: 6.9% (down from 7.8% in 2Q 2023). Revenue is forecast to grow 6.9% p.a. on average during the next 2 years, compared to a 7.6% growth forecast for the Electrical industry in Germany. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Aankondiging • Jul 12
Ultralife Corporation to Report Q2, 2024 Results on Jul 25, 2024 Ultralife Corporation announced that they will report Q2, 2024 results Pre-Market on Jul 25, 2024 Aankondiging • May 31
Ultralife Corporation, Annual General Meeting, Jul 16, 2024 Ultralife Corporation, Annual General Meeting, Jul 16, 2024. Location: eastern time at the sheraton charlotte, airport hotel located at 3315, scott futrell drive, nc 28202, charlotte United States New Risk • Apr 27
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 46% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (2.1% increase in shares outstanding). Reported Earnings • Apr 26
First quarter 2024 earnings released: EPS: US$0.18 (vs US$0.021 loss in 1Q 2023) First quarter 2024 results: EPS: US$0.18 (up from US$0.021 loss in 1Q 2023). Revenue: US$41.9m (up 31% from 1Q 2023). Net income: US$2.89m (up US$3.24m from 1Q 2023). Profit margin: 6.9% (up from net loss in 1Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Aankondiging • Apr 12
Ultralife Corporation to Report Q1, 2024 Results on Apr 25, 2024 Ultralife Corporation announced that they will report Q1, 2024 results Pre-Market on Apr 25, 2024 New Risk • Apr 02
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 20% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 58% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.3% average weekly change). Large one-off items impacting financial results. Reported Earnings • Mar 23
Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022) Full year 2023 results: EPS: US$0.44 (up from US$0.007 loss in FY 2022). Revenue: US$158.6m (up 20% from FY 2022). Net income: US$7.20m (up US$7.32m from FY 2022). Profit margin: 4.5% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Mar 19
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €7.50, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 15x in the Electrical industry in Germany. Total returns to shareholders of 15% over the past three years. Reported Earnings • Feb 17
Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022) Full year 2023 results: EPS: US$0.44 (up from US$0.007 loss in FY 2022). Revenue: US$158.6m (up 20% from FY 2022). Net income: US$7.20m (up US$7.32m from FY 2022). Profit margin: 4.5% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Feb 16
Investor sentiment improves as stock rises 31% After last week's 31% share price gain to €8.55, the stock trades at a trailing P/E ratio of 36.7x. Average trailing P/E is 19x in the Electrical industry in Europe. Total returns to shareholders of 50% over the past three years. Aankondiging • Jan 30
Ultralife Corporation to Report Q4, 2023 Results on Feb 15, 2024 Ultralife Corporation announced that they will report Q4, 2023 results Pre-Market on Feb 15, 2024 Recent Insider Transactions • Dec 10
Independent Chairman recently bought €103k worth of stock On the 8th of December, Bradford Whitmore bought around 16k shares on-market at roughly €6.50 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth €165k. Bradford has been a buyer over the last 12 months, purchasing a net total of €1.4m worth in shares. Recent Insider Transactions • Dec 01
Independent Chairman recently bought €165k worth of stock On the 29th of November, Bradford Whitmore bought around 25k shares on-market at roughly €6.56 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of €1.5m worth in shares. Recent Insider Transactions • Nov 03
Independent Chairman recently bought €94k worth of stock On the 1st of November, Bradford Whitmore bought around 14k shares on-market at roughly €6.77 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth €105k. Bradford has been a buyer over the last 12 months, purchasing a net total of €1.4m worth in shares. Reported Earnings • Oct 27
Third quarter 2023 earnings released: EPS: US$0.082 (vs US$0.015 loss in 3Q 2022) Third quarter 2023 results: EPS: US$0.082 (up from US$0.015 loss in 3Q 2022). Revenue: US$39.5m (up 19% from 3Q 2022). Net income: US$1.33m (up US$1.57m from 3Q 2022). Profit margin: 3.4% (up from net loss in 3Q 2022). The move to profitability was driven by higher revenue. Revenue is forecast to grow 9.9% p.a. on average during the next 2 years, compared to a 9.7% growth forecast for the Electrical industry in Germany. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Oct 26
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to €7.60, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 13x in the Electrical industry in Europe. Total returns to shareholders of 65% over the past three years. Aankondiging • Oct 13
Ultralife Corporation to Report Q3, 2023 Results on Oct 26, 2023 Ultralife Corporation announced that they will report Q3, 2023 results Pre-Market on Oct 26, 2023 Recent Insider Transactions • Sep 17
Independent Chairman recently bought €105k worth of stock On the 15th of September, Bradford Whitmore bought around 11k shares on-market at roughly €9.51 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of €1.3m worth in shares. Valuation Update With 7 Day Price Move • Aug 23
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to €9.60, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 15x in the Electrical industry in Europe. Total returns to shareholders of 81% over the past three years. Valuation Update With 7 Day Price Move • Aug 03
Investor sentiment improves as stock rises 74% After last week's 74% share price gain to €7.60, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 15x in the Electrical industry in Europe. Total returns to shareholders of 31% over the past three years. New Risk • Jul 29
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company. Reported Earnings • Jul 28
Second quarter 2023 earnings released: EPS: US$0.21 (vs US$0.032 in 2Q 2022) Second quarter 2023 results: EPS: US$0.21 (up from US$0.032 in 2Q 2022). Revenue: US$42.7m (up 33% from 2Q 2022). Net income: US$3.34m (up US$2.83m from 2Q 2022). Profit margin: 7.8% (up from 1.6% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.2% p.a. on average during the next 2 years, compared to a 8.4% growth forecast for the Electrical industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance. Aankondiging • Jul 14
Ultralife Corporation to Report Q2, 2023 Results on Jul 27, 2023 Ultralife Corporation announced that they will report Q2, 2023 results Pre-Market on Jul 27, 2023 Recent Insider Transactions • Jun 17
Independent Chairman recently bought €367k worth of stock On the 14th of June, Bradford Whitmore bought around 81k shares on-market at roughly €4.55 per share. This transaction amounted to 1.5% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of €1.8m worth in shares. Recent Insider Transactions • Jun 03
Independent Chairman recently bought €136k worth of stock On the 1st of June, Bradford Whitmore bought around 34k shares on-market at roughly €4.01 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of €1.6m worth in shares. Aankondiging • May 31
Ultralife Corporation, Annual General Meeting, Jul 19, 2023 Ultralife Corporation, Annual General Meeting, Jul 19, 2023, at 09:00 US Eastern Standard Time. Location: Ultralife Corporation Headquarters located at 2000 Technology Parkway, Newark New York United States Agenda: To consider Election of directors; to consider ratification of the selection of Freed Maxick CPAs, P.C. as company's independent registered public accounting firm for the fiscal year ending December 31, 2023; to consider and vote on a non-binding advisory resolution on executive compensation; to vote on a non-binding advisory resolution on the frequency of future advisory votes on executive compensation; and to consider other matters. Recent Insider Transactions • May 13
Independent Chairman recently bought €107k worth of stock On the 11th of May, Bradford Whitmore bought around 29k shares on-market at roughly €3.72 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth €114k. Bradford has been a buyer over the last 12 months, purchasing a net total of €1.4m worth in shares. Reported Earnings • Apr 06
Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021) Full year 2022 results: US$0.007 loss per share (improved from US$0.015 loss in FY 2021). Revenue: US$131.8m (up 34% from FY 2021). Net loss: US$119.0k (loss narrowed 49% from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Mar 18
Independent Chairman recently bought €114k worth of stock On the 13th of March, Bradford Whitmore bought around 30k shares on-market at roughly €3.79 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of €1.3m worth in shares. Reported Earnings • Mar 03
Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021) Full year 2022 results: US$0.007 loss per share (improved from US$0.015 loss in FY 2021). Revenue: US$131.8m (up 34% from FY 2021). Net loss: US$119.0k (loss narrowed 49% from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Dec 11
Independent Chairman recently bought €264k worth of stock On the 8th of December, Bradford Whitmore bought around 69k shares on-market at roughly €3.82 per share. This transaction amounted to 1.3% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of €1.6m worth in shares. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 5 highly experienced directors. CEO, President & Director Mike Popielec was the last director to join the board, commencing their role in 2010. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 28
Third quarter 2022 earnings released: US$0.015 loss per share (vs US$0.036 loss in 3Q 2021) Third quarter 2022 results: US$0.015 loss per share (improved from US$0.036 loss in 3Q 2021). Revenue: US$33.2m (up 53% from 3Q 2021). Net loss: US$239.0k (loss narrowed 59% from 3Q 2021). Revenue is forecast to grow 8.4% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electrical industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance. Aankondiging • Oct 14
Ultralife Corporation to Report Q3, 2022 Results on Oct 27, 2022 Ultralife Corporation announced that they will report Q3, 2022 results on Oct 27, 2022 Recent Insider Transactions • Aug 21
Independent Chairman recently bought €156k worth of stock On the 18th of August, Bradford Whitmore bought around 34k shares on-market at roughly €4.56 per share. In the last 3 months, they made an even bigger purchase worth €457k. Bradford has been a buyer over the last 12 months, purchasing a net total of €1.3m worth in shares. Recent Insider Transactions • Aug 06
Independent Chairman recently bought €457k worth of stock On the 4th of August, Bradford Whitmore bought around 100k shares on-market at roughly €4.57 per share. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of €1.1m worth in shares. Reported Earnings • Jul 29
Second quarter 2022 earnings released: EPS: US$0.032 (vs US$0.051 in 2Q 2021) Second quarter 2022 results: EPS: US$0.032 (down from US$0.051 in 2Q 2021). Revenue: US$32.1m (up 20% from 2Q 2021). Net income: US$512.0k (down 37% from 2Q 2021). Profit margin: 1.6% (down from 3.0% in 2Q 2021). Over the next year, revenue is forecast to grow 24%, compared to a 17% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance. Aankondiging • Jul 15
Ultralife Corporation to Report Q2, 2022 Results on Jul 28, 2022 Ultralife Corporation announced that they will report Q2, 2022 results Pre-Market on Jul 28, 2022 Recent Insider Transactions • Jun 11
Independent Chairman recently bought €204k worth of stock On the 8th of June, Bradford Whitmore bought around 43k shares on-market at roughly €4.75 per share. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of €854k worth in shares. Aankondiging • Jun 01
Ultralife Corporation, Annual General Meeting, Jul 20, 2022 Ultralife Corporation, Annual General Meeting, Jul 20, 2022, at 09:00 US Eastern Standard Time. Location: The Westin Detroit Metropolitan Airport located at 2501 Worldgateway Place, Detroit, MI 48242 Detroit United States Agenda: To elect five directors for a term of one year and until their successors are duly elected and qualified; to ratify the selection of Freed Maxick CPAs, P.C. as company's independent registered public accounting firm for the fiscal year ending December 31, 2022; and to transact such other business as may properly come before the meeting and any adjournments thereof. Reported Earnings • Apr 29
First quarter 2022 earnings released: US$0.01 loss per share (vs US$0.042 profit in 1Q 2021) First quarter 2022 results: US$0.01 loss per share (down from US$0.042 profit in 1Q 2021). Revenue: US$30.4m (up 17% from 1Q 2021). Net loss: US$168.0k (down 125% from profit in 1Q 2021). Over the next year, revenue is forecast to grow 24%, compared to a 12% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 5 highly experienced directors. CEO, President & Director Mike Popielec was the last director to join the board, commencing their role in 2010. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Aankondiging • Apr 15
Ultralife Corporation to Report Q1, 2022 Results on Apr 28, 2022 Ultralife Corporation announced that they will report Q1, 2022 results Pre-Market on Apr 28, 2022 Reported Earnings • Mar 10
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: US$0.015 loss per share (down from US$0.33 profit in FY 2020). Revenue: US$98.3m (down 8.8% from FY 2020). Net loss: US$234.0k (down 105% from profit in FY 2020). Revenue exceeded analyst estimates by 3.4%. Over the next year, revenue is forecast to grow 26%, compared to a 16% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Mar 05
Independent Chairman recently bought €218k worth of stock On the 28th of February, Bradford Whitmore bought around 55k shares on-market at roughly €3.96 per share. In the last 3 months, they made an even bigger purchase worth €263k. Bradford has been a buyer over the last 12 months, purchasing a net total of €649k worth in shares. Reported Earnings • Feb 04
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: US$0.015 loss per share (down from US$0.33 profit in FY 2020). Revenue: US$98.3m (down 8.8% from FY 2020). Net loss: US$234.0k (down 105% from profit in FY 2020). Revenue exceeded analyst estimates by 3.4%. Over the next year, revenue is forecast to grow 17%, compared to a 14% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 69 percentage points per year, which is a significant difference in performance. Aankondiging • Dec 15
Ultralife Corporation (NasdaqGM:ULBI) acquired Excell Battery Company for $23.5 million. Ultralife Corporation (NasdaqGM:ULBI) acquired Excell Battery Company for $23.5 million on December 14, 2021. Ultralife acquired all of the outstanding shares of Excell Battery Group for $23.5 million in cash, subject to customary working capital and net cash adjustments. For the trailing twelve-month period ended November 30, 2021, Excell generated revenues of $21.2 million. The transaction is expected to be accretive on an EPS basis within twelve months.
Ultralife Corporation (NasdaqGM:ULBI) completed the acquisition of Excell Battery Company on December 14, 2021. Reported Earnings • Oct 29
Third quarter 2021 earnings released: US$0.036 loss per share (vs US$0.026 profit in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: US$21.8m (down 11% from 3Q 2020). Net loss: US$585.0k (down 244% from profit in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 62% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Recent Insider Transactions • Aug 06
Independent Chairman recently bought €168k worth of stock On the 4th of August, Bradford Whitmore bought around 25k shares on-market at roughly €6.68 per share. This was the largest purchase by an insider in the last 3 months. This was Bradford's only on-market trade for the last 12 months. Reported Earnings • Jul 30
Second quarter 2021 earnings released: EPS US$0.051 (vs US$0.10 in 2Q 2020) The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$26.8m (down 6.3% from 2Q 2020). Net income: US$811.0k (down 51% from 2Q 2020). Profit margin: 3.0% (down from 5.8% in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. 
